English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52511040    線上人數 :  840
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至: [ 中文 ] [ 數字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
請輸入前幾個字:   

顯示項目 646886-646895 / 2348570 (共234857頁)
<< < 64684 64685 64686 64687 64688 64689 64690 64691 64692 64693 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立交通大學 2014-12-08T15:38:19Z Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells Liu, Huei-Fang; Hu, Huai-Chin; Chao, Jui-I
國家衛生研究院 2017-12-16 Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis Hsu, HH;Chen, MC;Baskaran, R;Lin, YM;Day, CH;Lin, YJ;Tu, CC;Padma, VV;Kuo, WW;Huang, CY
亞洲大學 2017-12 Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis Hs, Hsi-Hsien;Hsu, Hsi-Hsien;Ming-Cheng, Cheng C;Chen, Ming-Cheng;Rathinasamy;Baskaran, Rathinasamy;Lin, Yueh-Min;Cecilia, H. D;Day, Cecilia H.;Lin, Yi-Jiun;Chuan-Chou, T;Tu, Chuan-Chou;Viswanadha, Viswanadha V;Padma, Viswanadha Vijaya;Kuo, Wei-Wen;黃志揚;Huang, Chih-yang
臺大學術典藏 2020-03-05T06:28:40Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Cheng A.-L.; Chang Y.-L.; Yeh K.-H.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liang J.-T.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; JAU-YU LIAU
國立臺灣大學 2014 Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients Lin, Yu-Lin; Liang, Yi-Hsin; Tsai, Jia-Huei; Liau, Jau-Yu; Liang, Jin-Tung; Lin, Been-Ren; Hung, Ji-Shiang; Lin, Liang-In; Tseng, Li-Hui; Chang, Yih-Leong; Yeh, Kun-Huei; Cheng, Ann-Lii; 梁逸歆; 林亮音; 曾麗慧; 張逸良; 林育麟; 鄭安理; 葉坤輝; 蔡佳惠; 洪基翔; 林本仁; 廖肇裕; 梁金銅
臺大學術典藏 2018-09-10T14:58:15Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients ANN-LII CHENG; Chang, Yih-Leong; Chang, Yih-Leong; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; LI-HUI TSENG; Lin, Yu-Lin; Liang, Yi-Hsin; Liang, Yi-Hsin; YIH-LEONG CHANG; Jin-Tung Liang; Chang, Jui-Hsing; Tsai, Jia-Huei; Liau, Jau-Yu; BEEN-REN LIN; JAU-YU LIAU; Liang, Jin-Tung; Lin, Been-Ren; LIANG-IN LIN; Lin, Been-Ren; Hung, Ji-Shiang; KUN-HUEI YEH; Ji-Shiang Hung; Lin, Liang-In; Tseng, Li-Hui; 梁逸歆;林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;蔡佳惠;洪基翔;林本仁;廖肇裕;梁金銅; 梁逸歆;林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;蔡佳惠;洪基翔;林本仁;廖肇裕;梁金銅
臺大學術典藏 2020-02-25T05:15:26Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Liau J.-Y.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.
臺大學術典藏 2021-05-03T02:20:57Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2022-03-10T07:58:43Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2021-05-07T02:46:38Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; YI-HSIN LIANG; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.

顯示項目 646886-646895 / 2348570 (共234857頁)
<< < 64684 64685 64686 64687 64688 64689 64690 64691 64692 64693 > >>
每頁顯示[10|25|50]項目